SPINEX, INC.
Medtech · Private
Transcutaneous spinal neuromodulation system for cerebral palsy rehabilitation
- Grants
- $4.0M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 7
- 0 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Development of Transcutaneous Electrical Spinal Cord Neuromodulator for Home Use | $255,568 | |
| Federal grant | Department of Health and Human Services · Phase II · Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder | $956,407 | |
| Federal grant | Department of Health and Human Services · Phase II · Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder | $924,935 | |
| Federal grant | Department of Health and Human Services · Phase II · Spinal Cord Innovation in Pediatrics to Treat Cerebral Palsy (SCiP Clinical Study) | $924,592 | |
| Federal grant | Department of Health and Human Services · Phase II · Spinal Cord Innovation in Pediatrics to Treat Cerebral Palsy (SCiP Clinical Study) | $913,646 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1955 | NOVAFLUX, INC. | — | — |
| 1956 | Artisight, Inc. | — | — |
| 1957 | ENDOMIMETICS LLC | — | — |
| 1958 | SPINEX, INC. | — | — |
| 1959 | ALLAY THERAPEUTICS INC | — | — |
| 1960 | LO BIOSCIENCES, INC. | — | — |
| 1961 | ESCHARA MEDICAL, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Wearable Non-Invasive Central Nervous System Neuromodulator and Methods for Using Sameapplication
- Methods For Non-invasive Spinal Neuromodulation For Treating Diabetes And Systems For Sameapplication
- Methods For Non-invasive Spinal Neuromodulation For Treating Diabetes And Systems For Sameapplication
- Wearable Non-Invasive Central Nervous System Neuromodulator and Methods for Using Sameapplication
- Wearable Non-Invasive Central Nervous System Neuromodulator and Methods for Using Sameapplication
- Wearable Non-invasive Central Nervous System Neuromodulator And Methods For Using Sameapplication
- Wearable Non-invasive Central Nervous System Neuromodulator And Methods For Using Sameapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.